Ontology highlight
ABSTRACT: Aim
The aim of the present study was to evaluate the effect of E-OA-07 on individuals having osteoarthritis of the knee.Background
Lanconone® (E-OA-07) is a widely marketed dietary supplement which has been previously studied in different clinical settings for managing chronic joint pain. This was a confirmatory study planned at a lowered dose regimen with the purpose of improving compliance and reducing consumer cost.Methods
Male and female participants aged between 40 and 65 years, with history of joint pain for at least 3 years, were recruited. Knee joint dysfunction of grade II/III was radiographically characterized as per Kellgren-Lawrence system of classification. Enrolled participants were randomized to receive E-OA-07 at a dose of 1000 mg/day or p
SUBMITTER: Srivastava S
PROVIDER: S-EPMC6927262 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature